Antiplasmodial and antileishmanial activities of compounds from Piper tuberculatum Jacq fruits.

INTRODUCTION: This study assessed the activity of compounds from Piper tuberculatum against Plasmodium falciparum and Leishmania guyanensis. METHODS: The effects of compounds from P. tuberculatum fruits on P. falciparum and L. guyanensis promastigote growth in vitro were determined. Hemolytic action and cytotoxicity in HepG2 and J774 cells were measured. RESULTS: Three compounds showed strong antiplasmodial activity and one compound showed strong antileishmanial activity. Two compounds were non-toxic to HepG2 cells and all were toxic to J774 cells. The compounds showed no hemolytic activity. CONCLUSIONS: The tested compounds from P. tuberculatum exhibited antiparasitic and cytotoxic effects.

Antiplasmodial and antileishmanial activities of compounds from Piper tuberculatum Jacq fruits

Abstract INTRODUCTION This study assessed the activity of compounds from Piper tuberculatum against Plasmodium falciparum and Leishmania guyanensis. METHODS The effects of compounds from P. tuberculatum fruits on P. falciparum and L. guyanensis promastigote growth in vitro were determined. Hemolytic action and cytotoxicity in HepG2 and J774 cells were measured. RESULTS Three compounds showed strong antiplasmodial activity and one compound showed strong antileishmanial activity. Two compounds were non-toxic to HepG2 cells and all were toxic to J774 cells. The compounds showed no hemolytic activity. CONCLUSIONS The tested compounds from P. tuberculatum exhibited antiparasitic and cytotoxic effects.

Evaluation of the antiplasmodial and leishmanicidal potential of Myrciaria dubia (Myrtaceae) extract.

INTRODUCTION:: Malaria and leishmaniasis are prevalent in tropical regions, which have environmental characteristics that are highly favorable to protozoa and vectors of these diseases; the transmission of these infections in sub-tropical regions, although recognized, represents only a small fraction of cases. Plants are constantly being used in the search for and acquisition of new drugs, and many compounds derived from them have been used to combat various diseases. In this study, we evaluated the action of the dichloromethanolic extract of Myrciaria dubia leaves against the protozoa Plasmodium falciparum, Leishmania amazonensis, Leishmania braziliensis, and Leishmania chagasi through bioassays. METHODS: The extract from M. dubia was tested for its anti-P. falciparum activity in an anti-histidine-rich protein II immunosorbent assay. The antileishmanial assays were performed using the resazurin method, while cytotoxicity against human hepatoma (HepG2) strain was determined using the colorimetric MTT [3-(4, 5-dimethyl-2- thiazolyl)-2, 5-diphenyl-2H tetrazolium bromide] method. RESULTS: The M. dubia extract presented a half-maximal inhibitory concentration equal to 2.35 (1.05)µg/mL for P. falciparum, 190.73 (6.41) µg/mL for L. amazonensis, and greater than equal to 200µg/mL for L. chagasi and L. braziliensis strains. The cytotoxic concentration for 50% of the cells was above 500µg/mL for HepG2, indicating no toxicity and greater selectivity against parasites. CONCLUSIONS: The results obtained indicate the presence of antiplasmodial and leishmanicidal bioactive compounds in the dichloromethanolic extracts of M. dubia leaves, and point towards future studies to elucidate the mechanism of action for each physiological effect.

Evaluation of the antiplasmodial and leishmanicidal potential of Myrciaria dubia (Myrtaceae) extract

Abstract INTRODUCTION: Malaria and leishmaniasis are prevalent in tropical regions, which have environmental characteristics that are highly favorable to protozoa and vectors of these diseases; the transmission of these infections in sub-tropical regions, although recognized, represents only a small fraction of cases. Plants are constantly being used in the search for and acquisition of new drugs, and many compounds derived from them have been used to combat various diseases. In this study, we evaluated the action of the dichloromethanolic extract of Myrciaria dubia leaves against the protozoa Plasmodium falciparum, Leishmania amazonensis, Leishmania braziliensis, and Leishmania chagasi through bioassays. METHODS The extract from M. dubia was tested for its anti-P. falciparum activity in an anti-histidine-rich protein II immunosorbent assay. The antileishmanial assays were performed using the resazurin method, while cytotoxicity against human hepatoma (HepG2) strain was determined using the colorimetric MTT [3-(4, 5-dimethyl-2- thiazolyl)-2, 5-diphenyl-2H tetrazolium bromide] method. RESULTS The M. dubia extract presented a half-maximal inhibitory concentration equal to 2.35 (1.05)μg/mL for P. falciparum, 190.73 (6.41) μg/mL for L. amazonensis, and greater than equal to 200µg/mL for L. chagasi and L. braziliensis strains. The cytotoxic concentration for 50% of the cells was above 500μg/mL for HepG2, indicating no toxicity and greater selectivity against parasites. CONCLUSIONS The results obtained indicate the presence of antiplasmodial and leishmanicidal bioactive compounds in the dichloromethanolic extracts of M. dubia leaves, and point towards future studies to elucidate the mechanism of action for each physiological effect.

Efeito leishmanicida in vitro do látex de Croton lechleri (Euphorbiaceae) / In vitro leishmanicidal effect of Croton lechleri latex

A Leishmaniose Tegumentar Americana é uma infecção causada por uma variedade de espécies de Leishmania, é transmitida ao homem por flebotomíneos. Os antimoniais pentavalentes são utilizados na quimioterapia dessa doença; no entanto, esses fármacos provocam uma série de efeitos colaterais, além de apresentar altos índices de toxicidade. Na busca por novos agentes leishmanicidas, avaliamos in vitro o extrato do látex de Croton lechleri (Sangue de dragão) frente a formas promastigotas de Leishmania amazonensis e Leishmania guyanensis. O extrato foi obtido através da desidratação do látex de C. lechleri e diluído em solução 10% de etanol em salina tamponada com fosfato. As promastigotas de Leishmania foram cultivadas juntamente com o extrato nas concentrações de 6,25; 12,5 e 25µg/ mL por 72 horas. O extrato apresentou eficácia em todas as concentrações testadas apresentando um IC50 (concentração inibitória) de 5,04µg/mL para L. amazonensis e IC50 de 9,05µg/mL para L. guyanensis. Foi realizada a avaliação citotóxica em células J774 nas mesmas concentrações usadas no ensaio leishmanicida, porém a concentração de 25µg/mL apresentou índice de toxicidade de aproximadamente 50% para a célula hospedeira. Os testes realizados mostraram-se promissores, pois o extrato testado também foi capaz de inibir o crescimento de promastigotas de L. amazonensis após ensaio de infecção com células J774.

Cutaneous Leishmaniasis is an infection caused by a several species of Leishmania, is transmitted to humans by phlebotomine sandflies. Pentavalent antimonial compounds are used in the chemotherapy of this disease; however, these drugs cause several collateral effects, besides presenting high levels of toxicity. The search for new antiLeishmanial agents, we assessed in vitro the extract of Croton lechleri latex (Blood Dragon) against the promastigote forms of Leishmania amazonensis and Leishmania guyanensis. The extract was obtained by dehydration C. lechleri latex mass and the solution was diluted with 10% ethanol in phosphate buffered saline solution. The Leishmania promastigotes were grown with the extract following concentrations 6.25; 12.5 and 25µg/mL for 72 hours. The extract showed efficacy in all concentrations tested showing an IC50 (inhibitory concentration) of 5.04 µg/mL for L. amazonensis and IC50 of 9.05 µg/mL for L. guyanensis. Cytotoxic evaluation was performed in J774 cells at the same concentrations used in the leishmanicidal assay, but the concentration of 25µg/mL showed toxicity index of approximately 50% for the host cell. Tests carried out proved promising, since the extracts tested was also able to inhibit the L. amazonensis promastigotes growth after infection assay with J774 cells.

A lupane-triterpene isolated from Combretum leprosum Mart. fruit extracts that interferes with the intracellular development of Leishmania (L.) amazonensis in vitro.

BACKGROUND: 3beta,6beta,16beta-trihydroxylup-20(29)-ene is a lupane triterpene isolated from Combretum leprosum fruit. The lupane group has been extensively used in studies on anticancer effects; however, its possible activity against protozoa parasites is yet poorly known. The high toxicity of the compounds currently used in leishmaniasis chemotherapy stimulates the investigation of new molecules and drug targets for antileishmanial therapy. METHODS: The activity of 3beta,6beta,16beta-trihydroxylup-20(29)-ene was evaluated against Leishmania (L.) amazonensis by determining the cytotoxicity of the compound on murine peritoneal macrophages, as well as its effects on parasite survival inside host cells. To evaluate the effect of this compound on intracellular amastigotes, cultures of infected macrophages were treated for 24, 48 and 96 h and the percentage of infected macrophages and the number of intracellular parasites was scored using light microscopy. RESULTS: Lupane showed significant activity against the intracellular amastigotes of L. (L.) amazonensis. The treatment with 109 µM for 96 h reduced in 80 % the survival index of parasites in BALB/c peritoneal macrophages. At this concentration, the triterpene caused no cytotoxic effects against mouse peritoneal macrophages. Ultrastructural analyses of L. (L.) amazonensis intracellular amastigotes showed that lupane induced some morphological changes in parasites, such as cytosolic vacuolization, lipid body formation and mitochondrial swelling. Bioinformatic analyses through molecular docking suggest that this lupane has high-affinity binding with DNA topoisomerase. CONCLUSION: Taken together, our results have showed that the lupane triterpene from C. leprosum interferes with L. (L.) amazonensis amastigote replication and survival inside vertebrate host cells and bioinformatics analyses strongly indicate that this molecule may be a potential inhibitor of topoisomerase IB. Moreover, this study opens major prospects for the development of novel chemotherapeutic agents with leishmanicidal activity.